Literature DB >> 25755558

Hepatobiliary quiz-10 (2014).

Swastik Agrawal1, Radha K Dhiman1.   

Abstract

Year:  2014        PMID： 25755558      PMCID： PMC4188822          DOI： 10.1016/j.jceh.2014.05.011

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN： 0973-6883


× No keyword cloud information.
  48 in total

1.  Massive hepatic fibrosis in Gaucher's disease: clinico-pathological and radiological features.

Authors:  R H Lachmann; D G Wight; D J Lomas; N C Fisher; J P Schofield; E Elias; T M Cox
Journal:  QJM       Date:  2000-04

2.  Genetic fine localization of the beta-glucocerebrosidase (GBA) and prosaposin (PSAP) genes: implications for Gaucher disease.

Authors:  B Cormand; M Montfort; A Chabás; L Vilageliu; D Grinberg
Journal:  Hum Genet       Date:  1997-07       Impact factor: 4.132

3.  Partial internal biliary diversion for patients with progressive familial intrahepatic cholestasis type 1.

Authors:  Kyoko Mochizuki; Masayuki Obatake; Mitsuhisa Takatsuki; Akiko Nakatomi; Tomayoshi Hayashi; Sadayuki Okudaira; Susumu Eguchi
Journal:  Pediatr Surg Int       Date:  2012-01       Impact factor: 1.827

Review 4.  Portal hypertensive biliopathy.

Authors:  Radha K Dhiman; Arunanshu Behera; Yogesh K Chawla; Jang B Dilawari; Sudha Suri
Journal:  Gut       Date:  2006-12-14       Impact factor: 23.059

Review 5.  Gaucher disease.

Authors:  Aabha Nagral
Journal:  J Clin Exp Hepatol       Date:  2014-04-21

Review 6.  Endoscopic management of portal cavernoma cholangiopathy: practice, principles and strategy.

Authors:  Vivek A Saraswat; Praveer Rai; Tarun Kumar; Samir Mohindra; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2013-10-22

Review 7.  FIC1 disease: a spectrum of intrahepatic cholestatic disorders.

Authors:  S W van Mil; L W Klomp; L N Bull; R H Houwen
Journal:  Semin Liver Dis       Date:  2001-11       Impact factor: 6.115

Review 8.  Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease.

Authors:  Silvia Sookoian; Carlos J Pirola
Journal:  Hepatology       Date:  2011-05-14       Impact factor: 17.425

9.  Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial.

Authors:  Stephen A Harrison; Will Fecht; Elizabeth M Brunt; Brent A Neuschwander-Tetri
Journal:  Hepatology       Date:  2009-01       Impact factor: 17.425

10.  Type 1 Gaucher disease: molecular, biochemical, and clinical characterization of patients from northern Portugal.

Authors:  O Amaral; L Lacerda; R Santos; R A Pinto; H Aerts; M C Sa Miranda
Journal:  Biochem Med Metab Biol       Date:  1993-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.